A lack of spatial context holds back how we understand diseases, like trying to fix a car without knowing how the engine works. That’s why A*STAR Genome Institute of Singapore’s TISHUMAP study is using Xenium #singlecellspatial data to train AI models, with the potential to improve drug target discovery, inform personalized medicine, and more. Learn how in this new GenomeWeb article: https://lnkd.in/gXxYS6Eb
10x Genomics
Biotechnology Research
Pleasanton, California 256,929 followers
Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬
About us
Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.
- Website
-
http://10xgenomics.com
External link for 10x Genomics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Pleasanton, California
- Type
- Public Company
- Founded
- 2012
Locations
-
Primary
6230 Stoneridge Mall Rd
Pleasanton, California 94588, US
Employees at 10x Genomics
Updates
-
Join us for this webinar featuring work from researchers at The University of Texas MD Anderson Cancer Center that identifies key B-cell lymphoma traits linked with greatest benefit from CD19 CAR T cell therapy: https://10xgen.com/1OS
-
-
See how the team at Weill Cornell Medicine used 10x Multiome with long read sequencing to simultaneously study chromatin accessibility and splicing across brain cell types! 🧠
Amazing work from Wen Hu, Hagen Tilgner and the team at Weill Cornell Medicine exploring the molecular complexity of brain cell types across species, regions and disease. ScISOr–ATAC combines Oxford Nanopore ultra-rich sequencing with single-cell ATAC and 10x cDNA barcoding—unlocking joint multiomic readouts directly from frozen tissue. The challenge: Can chromatin accessibility and RNA splicing be measured simultaneously in frozen brain tissue—resolving how gene regulation and isoform diversity interact across cell types, cortical regions, species, and Alzheimer’s disease? What they did: The team developed ScISOr–ATAC, a multimodal protocol to simultaneously measure chromatin accessibility and full-length isoform expression in the same single nuclei from human and macaque brain. They profiled over 19 human PFC samples (AD and control) and 4 macaque PFC and visual cortex samples, identifying how chromatin and splicing interplay differs between: Cortical regions Cell subtypes (especially excitatory neurons) Species (human vs macaque) Healthy and Alzheimer’s disease states Why it matters: This is one of the first large-scale demonstrations that splicing decisions are frequently tied to chromatin–transcription cell states, and that modalities can diverge sharply between species and in disease. It highlights the necessity of multimodal resolution—especially for understanding glial dysregulation in AD and species-specific divergence in neuron subtypes. Key findings: Splicing and chromatin decouple across regions: In macaques, L3–L5/L6 IT_RORB neurons showed strong brain-region-specific splicing, while L2–L4 IT_CUX2.RORB neurons had the most chromatin divergence. Divergence across species is cell-type-specific: Astrocytes showed the largest chromatin changes between human and macaque, whereas L2–L3 IT_NRGN.CBLN2 neurons showed high species-specific splicing. In Alzheimer’s disease, oligodendrocytes exhibited the strongest dysregulation in both chromatin and splicing, including loss of a regulatory exon in ZNF711, a gene linked to X-linked intellectual disability. Cell state matters: 55% of species-specific exons and a substantial proportion of AD-associated splicing changes were explained by distinct chromatin–transcriptome “cell states”. Legacy short-read methods? They cannot simultaneously resolve: Splice isoform usage and chromatin accessibility in the same nucleus Cell-state-resolved isoform shifts, particularly across primate species or in diseased tissue Exon-level inclusion variability within defined chromatin–transcription states Moreover, short-read data lacks the molecule-level phasing necessary to relate chromatin state to full isoform identity in complex tissues. The switch is ON. Daniel Garalde, Stephanie Abernathy Renner, Sissel Juul, 10x Genomics, Oxford Nanopore Technologies https://lnkd.in/e-h666Yi
-
Unsure which #singlecell assay is right for your research? Our latest blog post compares the capabilities of our Flex and Universal product families so you can find the perfect fit. Read now!
-
New on Xenium: integrated protein analysis with validated, ready-to-use panels! Now, you can simultaneously analyze 27 proteins & high-plex #singlecellspatial RNA for unmatched multiomic insights into #cancer, #immunology & more. Take a look at what it can do for you by exploring our dataset demo, then pre-order your assay today: https://bit.ly/4lGoHPR
-
-
#PTSD is debilitating and difficult to understand. Congratulations to Hwang et al. for their new Nature publication, where they combined Xenium #singlecellspatial with Chromium Multiome (#scRNAseq and ATAC-seq) to reveal how enrichment of the PTSD risk genes SST and FKBP5 offer novel mechanisms that contribute to the long-term effects of PTSD. Read it here: https://lnkd.in/eZfRhBVa
-
-
We’ve been pioneering #singlecell technology since 2012, and we’re just getting started. After over a decade of breakthroughs, single cell data is now fueling larger and more biologically relevant AI models than ever. See how single cell is driving the future of scientific discovery in a new Genetic Engineering & Biotechnology News article: https://lnkd.in/gd_PPwhU
-
-
Announcing TISHUMAP, a large-scale study combining expertise from A*STAR - Agency for Science, Technology and Research Genome Institute of Singapore (A*STAR GIS), 10x's cutting-edge Xenium #singlecellspatial platform, and advanced AI analyses to usher in a new era of precision medicine. This study will use thousands of Xenium-analyzed human samples to train AI models, improve drug target discovery, inform future strategies for personalized treatments, and more! Read the announcement here: https://bit.ly/40ZFvZs
-
Our engineers turn ideas into reality, challenges into breakthroughs, and ambitions into scientific progress. And our Singapore team is setting the bar higher than ever, providing opportunities for growth and the chance to make a real difference. See how you can help accelerate biological discovery by joining our R&D engineering team. Explore open positions: https://bit.ly/3ZYKkSR